Can a COPD inhaler also help your heart?
NCT ID NCT07073950
First seen Jun 26, 2026 · Last updated Jul 24, 2026 · Updated 3 times
Summary
This study tests a triple-combination inhaler (budesonide, glycopyrronium, and formoterol) against a placebo in 56 people with COPD and lung hyperinflation. The goal is to see if the inhaler improves both lung function and heart function, measured by MRI. Participants will receive the inhaler or placebo in a crossover design, meaning everyone gets both treatments at different times.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Budesonide/Glycopyrronium/Formoterol fumarate (a triple-combination inhaler)
- What this could lead to
- If it works, this could show that the inhaler improves both lung and heart function in people with COPD and hyperinflation, potentially leading to better management of the disease.
- What could go wrong
- This is a small, early-phase 4 trial with only 56 participants, so results may not apply to everyone. The study is also short-term, so long-term benefits or risks are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
RECRUITINGAhrensburg, 22926, Germany
-
Research Site
RECRUITINGBerlin, 14050, Germany
-
Research Site
RECRUITINGFrankfurt, 60596, Germany
-
Research Site
RECRUITINGHanover, 30625, Germany
-
Research Site
WITHDRAWNHarefield, UB9 6JH, United Kingdom
-
Research Site
RECRUITINGLondon, W1T 6AH, United Kingdom
-
Research Site
RECRUITINGManchester, M23 9QZ, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart breathing machines at home: a new way to predict COPD crises?
- Breathing easy? new X-Ray method may spot COPD decline early
- Could a common heart drug cut COPD hospitalizations?
- Which inhaler breathes better? a Head-to-Head COPD showdown
- Could tiny lung valves revive heart and muscle strength in COPD?
- One lung or two? surgery trial aims to find the best approach for severe COPD